Jinhe Biotechnology (China) Analysis

Jinhe Stock Analysis Notes

About 46.0% of the company shares are owned by insiders or employees . The company has Price-to-Book (P/B) ratio of 1.57. In the past many companies with similar price-to-book ratios have beat the market. Jinhe Biotechnology last dividend was issued on the 31st of May 2024. The entity had 25:10 split on the 17th of May 2016. For more info on Jinhe Biotechnology Co check out https://www.jinhe.com.cn.

Jinhe Biotechnology Investment Alerts

Jinhe Biotechnology Thematic Classifications

Jinhe Market Capitalization

The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.56 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Jinhe Biotechnology's market, we take the total number of its shares issued and multiply it by Jinhe Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Jinhe Profitablity

The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.13 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.13.

Management Efficiency

Jinhe Biotechnology has return on total asset (ROA) of 0.0223 % which means that it generated a profit of $0.0223 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0371 %, meaning that it generated $0.0371 on every $100 dollars invested by stockholders. Jinhe Biotechnology's management efficiency ratios could be used to measure how well Jinhe Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. At present, Jinhe Biotechnology's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 3.6 B, whereas Non Currrent Assets Other are forecasted to decline to about 58.5 M.

Technical Drivers

As of the 29th of November, Jinhe Biotechnology retains the Market Risk Adjusted Performance of (5.00), risk adjusted performance of 0.1342, and Downside Deviation of 1.98. Jinhe Biotechnology technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Jinhe Biotechnology Price Movement Analysis

Jinhe Biotechnology Outstanding Bonds

Jinhe Biotechnology Predictive Daily Indicators

Jinhe Biotechnology Forecast Models

Jinhe Biotechnology's time-series forecasting models are one of many Jinhe Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Jinhe Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Jinhe Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Jinhe shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Jinhe Biotechnology. By using and applying Jinhe Stock analysis, traders can create a robust methodology for identifying Jinhe entry and exit points for their positions.

When running Jinhe Biotechnology's price analysis, check to measure Jinhe Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jinhe Biotechnology is operating at the current time. Most of Jinhe Biotechnology's value examination focuses on studying past and present price action to predict the probability of Jinhe Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jinhe Biotechnology's price. Additionally, you may evaluate how the addition of Jinhe Biotechnology to your portfolios can decrease your overall portfolio volatility.